SUPERA S-60-030-120-P6Recalls & reported problems
Abbott Vascular Inc. · Supera Peripheral Stent System 6 mm x 30 mm x 120 cm 6 F · Class 3 · Implant
All models of SUPERA (55)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648211881), received between Aug 30, 2016 and Dec 30, 2025 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Difficult or Delayed Activation” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Difficult or Delayed Activation1
- Material Separation1
- Physical Resistance/Sticking1
Patient problems
- Insufficient Information1
- No Clinical Signs, Symptoms or Conditions1
- Stenosis1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 30, 2025Difficult or Delayed Activation; Physical Resistance/Sticking; Difficult or Delayed Activation; Physical Resistance/Sticking
IT WAS REPORTED THAT THE PROCEDURE PERFORMED WAS TO TREAT THE LEFT ANTERIOR TIBIAL ARTERY. THE RATCHET [THUMBSLIDE] WAS NOT CATCHING THE DEVICE AND DIFFICULTY WAS NOTED DURING DEPLOYMENT OF THE 6.0X30MM SUPERA SELF-EXPANDING STENT OVER A 0.018 GUIDEWIRE. AFTER MANIPULATION WITH THE CATHETER, THE SES WAS ABLE TO FULLY DEPLOY. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23928774 ↗MalfunctionFeb 4, 2021Material Separation; Material Separation
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A NON-CALCIFIED, MILDLY TORTUOUS RIGHT SUPERFICIAL FEMORAL ARTERY. PRE-DILATATION WAS DONE WITH A 6.0X40MM ARMADA 18 BALLOON INFLATED TO NOMINAL AT 8ATM FOR 2 MINUTES. THE 6.0X30MM SUPERA SELF-EXPANDING STENT SYSTEM (SESS) WAS ADVANCED USING A 6F SHEATH (55CM), UP AND OVER THE ILIAC, WITH NO RESISTANCE. THEN UPON DEPLOYMENT, IT WAS OBSERVED UNDER FLUOROSCOPY THAT THE NOSE CONE WAS STARTING TO BECOME DETACHED. THEREFORE, THE PHYSICIAN QUICKLY FINISHED DEPLOYING THE STENT AND A DECISION WAS MADE TO RETRACT THE THUMB SLIDE BACK TO REMOVE THE SYSTEM WITH THE GUIDEWIRE AS A SINGLE UNIT. AFTER THE DEVICES WERE SUCCESSFULLY REMOVED FROM THE PATIENT, THE PHYSICIAN PULLED ON THE NOSE CONE AND IT BECAME EASILY FULLY DETACHED. THE TARGET LESION WAS TREATED. THE PATIENT IS STABLE. NO OTHER ISSUES NOTED. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Insufficient Information
MAUDE report 11280237 ↗InjuryAug 30, 2016Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2016 THREE SUPERA STENTS WERE DEPLOYED IN THE SUPERFICIAL FEMORAL ARTERY. DUE TO RESTENOSIS OBSERVED IN THE PREVIOUSLY TREATED AREA, THE PATIENT UNDERWENT REVASCULARIZATION ON (B)(6) 2016. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Stenosis
MAUDE report 5914943 ↗
Other STENT, SUPERFICIAL FEMORAL ARTERY devices
- EverFlex™ EVD35-06-150-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 death110 reports
- SUPERA S-60-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY108 reports
- SUPERA S-55-150-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY88 reports
- LifeStent® Solo Vascular Stent EX062003CLBard Peripheral Vascular, Inc. · STENT, SUPERFICIAL FEMORAL ARTERY80 reports
- BioMimics 3D Vascular Stent System 144700-12Veryan Medical Limited · Stent, Superficial Femoral Artery74 reports
- SUPERA S-50-120-120-P6Abbott Vascular Inc. · STENT, SUPERFICIAL FEMORAL ARTERY55 reports
- EverFlex™ EVD35-07-060-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
- EverFlex™ EVD35-07-120-120Covidien LP · STENT, SUPERFICIAL FEMORAL ARTERY1 recall5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page